Updated Oct 28, 2026 · 12:56 UTC
BMYBristol-Myers Squibb Co.
Health Care · United States · XNYS · pharmaceutical preparations
$61.56−0.10%last session · market early-hours
Market cap
$125.75b
real-world
Tokenized
$3k
<0.001% of the asset
Avg token price
$61.71
Spot volume, 24h
—
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
BMY · Price
EarningsNasdaq’s earnings calendar
Next earnings
Oct 29
before the open · Sep 2026 quarter · EPS forecast $1.21 (9 analysts)
Last earnings, Jul 30
$2.04 EPS
+28.3% vs $1.59 forecast · Jun 2026 quarter
Real marketBristol-Myers Squibb Co.
Last close
$61.55
Oct 27
Traded on Oct 27
$477.7m
Price now
$61.56
market early-hours
Where it trades24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · — · 0 venues
None yet
Derivatives · — · 0 venues
None yet
In DeFiPools and lending markets that hold these tokens
None found
Onchain versions1 token from 1 issuer
wBMYxBacked Assets——Business 12 months to Jun 2026 · SEC EDGAR
Results
Revenue
$49.19b
+3% YoY
Net income
$9.28b
19% margin · +84% YoY
EPS, diluted
$4.53
+83% YoY
Diluted shares
2.05b
+0% YoY
Cash and balance sheet
Free cash flow
$11.44b
23% of revenue · 9.1% yield
Net debt
$31.66b
$11.46b cash and securities, $43.12b debt
Quarterly
RevenueNet income
Valuation today’s market cap $125.75b · enterprise value $157.40b
P/E
13.5×
EV / sales
3.2×